Azione 603669 LIONCO PHARMACEUTICAL GROUP CO.,LTD.
Aggiungi a un elenco
Solo clienti o iscritti possono usare questa funzione
AccediRegistrati

Altre lingue Lionco Pharmaceutical Group Co.,Ltd.

Azioni

603669

CNE1000022R8

Prezzo di chiusura Shanghai S.E.
Altri mercati azionari
 00:00:00 01/07/2024 		Variaz. 5gg Var. 1 gen.
4,73 CNY +0,21% Grafico intraday di Lionco Pharmaceutical Group Co.,Ltd. -1,25% -14,47%
19/04 Lionco Pharmaceutical Group Co.,Ltd. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024 CI
2023 Lionco Pharmaceutical Group Co.,Ltd. riporta i risultati degli utili per i nove mesi conclusi il 30 settembre 2023 CI

Altre lingue

Ricerca
Vedi i risultati
Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!
Registrazione 100% gratuita
Lionco Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Tranche Update on Lionco Pharmaceutical Group Co.,Ltd.'s Equity Buyback Plan announced on January 31, 2023.
Lionco Pharmaceutical Group Co.,Ltd.'s Equity Buyback announced on January 31, 2023, has closed with 8,785,900 shares, representing 1.22% for CNY 50 million.
Tranche Update on Lionco Pharmaceutical Group Co.,Ltd.'s Equity Buyback Plan announced on January 31, 2023.
Tranche Update on Lionco Pharmaceutical Group Co.,Ltd.'s Equity Buyback Plan announced on January 31, 2023.
Tranche Update on Lionco Pharmaceutical Group Co.,Ltd.'s Equity Buyback Plan announced on January 31, 2023.
Tranche Update on Lionco Pharmaceutical Group Co.,Ltd.'s Equity Buyback Plan announced on January 31, 2023.
Lionco Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Lionco Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Lionco Pharma Registers Latamoxef Sodium for Injection in China
Lionco Pharma's Bacterial Drug Passes Regulator's Evaluation
Lionco Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Lionco Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Lionco Pharma Unit's Aztreonam for Injection Passes Drug Regulator's Evaluation
Lionco Pharma to Raise Up to 100 Million Yuan Through Share Buyback
Lionco Pharmaceutical Group Co.,Ltd. announces an Equity Buyback for CNY 100 million worth of its shares.
Lionco Pharmaceutical Group Co.,Ltd. authorizes a Buyback Plan.
Tranche Update on Lionco Pharmaceutical Group Co.,Ltd.'s Equity Buyback Plan announced on March 10, 2022.
Lionco Pharmaceutical Group Co.,Ltd.'s Equity Buyback announced on March 10, 2022 has closed with 8,915,893 shares, for CNY 60 million.
Tranche Update on Lionco Pharmaceutical Group Co.,Ltd.'s Equity Buyback Plan announced on March 10, 2022.
Non ci sono risultati per questa ricerca
Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

Cerca

Data di pubblicazione

Da

A

  1. Borsa valori
  2. Azioni
  3. Azione 603669
  4. Notizie Lionco Pharmaceutical Group Co.,Ltd.
  5. Altre lingue